Cano-Gutiérrez Carlos, Salazar-Londoño Salomón, Botero-Rodriguez Felipe, Páez-García Salomón, Giraldo Salomón, Santacruz-Escudero José Manuel, Aarsland Dag, Borda Miguel Germán
Intellectus Memory and Cognition Center, Hospital Universitario San Ignacio, Bogotá, Colombia.
Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
Mov Disord Clin Pract. 2025 Apr 21. doi: 10.1002/mdc3.70059.
Dementia research in Latin America (LA) has primarily focused on Alzheimer's Disease and Frontotemporal Dementia, while Lewy body dementia (LBD) has been largely forgotten.
We aimed to review the available evidence on LBD in LA, offering a comprehensive perspective for understanding the lack of reports and the unique challenges and characteristics of this region.
We carried out a scoping review in databases: PubMed, EMBASE, LILACS, and Web of Science. Original studies that included participants with LBD were analyzed.
Of the 1388 studies identified, 70 met the inclusion criteria for this review. Among them, 63 were cross-sectional studies, three were cohort studies, two followed a case-control methodology, and only two were non-randomized clinical trials. These studies primarily examined clinical manifestations, risk factors, neuropsychiatric and non-motor symptoms, as well as cognitive impairment and its assessment in LBD within LA. Regarding geographical distribution, 52 studies were conducted in Brazil, seven in Argentina, the rest in Peru, Mexico, Colombia, Cuba, and Chile.
LBD research in LA is underrepresented, with most studies being cross-sectional, few utilizing a longitudinal design, and only two clinical trials, both of which lack rigorous methodology. Challenges include weak study designs, high heterogeneity, limited trials, and unclear differentiation within the LBD spectrum. Addressing these gaps requires increasing awareness, strengthening research capacity, securing funding, and fostering international collaboration.
拉丁美洲(LA)的痴呆症研究主要集中在阿尔茨海默病和额颞叶痴呆,而路易体痴呆(LBD)在很大程度上被忽视了。
我们旨在综述拉丁美洲关于路易体痴呆的现有证据,为理解该地区报告的缺乏以及该地区的独特挑战和特征提供全面的视角。
我们在PubMed、EMBASE、LILACS和科学网数据库中进行了一项范围综述。对纳入路易体痴呆患者的原始研究进行了分析。
在识别出的1388项研究中,70项符合本综述的纳入标准。其中,63项为横断面研究,3项为队列研究,2项采用病例对照方法,只有2项为非随机临床试验。这些研究主要考察了拉丁美洲路易体痴呆的临床表现、危险因素、神经精神和非运动症状,以及认知障碍及其评估。关于地理分布,52项研究在巴西进行,7项在阿根廷进行,其余在秘鲁、墨西哥、哥伦比亚、古巴和智利进行。
拉丁美洲路易体痴呆的研究代表性不足,大多数研究为横断面研究,很少采用纵向设计,只有两项临床试验,且两者都缺乏严谨的方法。挑战包括研究设计薄弱、异质性高、试验有限以及路易体痴呆谱系内的区分不明确。解决这些差距需要提高认识、加强研究能力、确保资金并促进国际合作。